chetomin has been researched along with Multiple Myeloma in 1 studies
chetomin: C31H30N6O6S4, similar to epipolythiodioxopiperazines
chetomin : An organic heteropentacyclic compound of the class of epipolythiodioxopiperazine. Isolated from Chaetomium globosum and Farrowia seminuda, it exhibits immunosuppressive activity.
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Viziteu, E | 1 |
| Grandmougin, C | 1 |
| Goldschmidt, H | 1 |
| Seckinger, A | 1 |
| Hose, D | 1 |
| Klein, B | 1 |
| Moreaux, J | 1 |
1 other study available for chetomin and Multiple Myeloma
| Article | Year |
|---|---|
Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Disulfides; Drug Screening Assays, Antitumor; E | 2016 |